Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1821-1826

  Lely, A Titia ^a,c   Krikken, Jan A ^a   Bakker, Stephan J L ^a   Boomsma, Frans ^b   Dullaart, Robin P F ^a   Wolffenbuttel, Bruce H R ^a   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; SODIUM; ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LEPTIN; RENIN;

ADULT; ARTICLE; BLOOD LEVEL; DRUG INFUSION; ENZYME INHIBITION; HIGH SODIUM INTAKE; HUMAN; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SODIUM RESTRICTION; VOLUNTEER; BLOOD; BLOOD PRESSURE; CHEMICAL PHENOMENA; DOSE RESPONSE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ANIMALIA;

ADIPONECTIN; ADULT; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; DEPRESSION, CHEMICAL; DIET, SODIUM-RESTRICTED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; LEPTIN; MALE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM;

EID: 34249860842     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2092     Document Type: Article

References (40)

1. Goldstein BJ, Scalia R 2004 Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563-2568
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
3. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58
4. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228
5. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y 2003 Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16:72-75
6. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB 2004 Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737
7. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737
8. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, Shimamoto K 2005 Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 153:91-98
9. Evans RM, Barish GD, Wang YX 2004 PPARs and the complex journey to obesity. Nat Med 10:355-361
10. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM 2002 The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974
11. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792
12. Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S, Bingol N, Bingol S, Vural A 2005 Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria. Nephron Clin Pract 99:c115-c121
13. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K 2003 Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42:76-81
14. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, Adachi M 2006 Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 55:478-488
15. 131I-hippuran. J Am Soc Nephrol 7:567-572
16. Derkx FH, Tan-Tjiong L, Wenting GJ, Boomsma F, Man in 't Veld AJ, Schalekamp MA 1983 Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 5:244-256
17. Admiraal PJ, Derkx FH, Danser AH, Pieterman H, Schalekamp MA 1990 Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15:44-55
18. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE 2004 Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256:324-330
19. Adamczak M, Chudek J, Wiecek A 2006 Influence of dietary sodium restriction and upright position on plasma adiponectin concentration in patients with essential hypertension. Nephrol Dial Transplant 21(Suppl 4):336
20. Hermann TS, Li W, Dominguez H, Ihlemann N, Rask-Madsen C, Major-Pedersen A, Nielsen DB, Hansen KW, Hawkins M, Kober L, Torp-Pedersen C 2006 Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. J Clin Endocrinol Metab 91:1001-1008
21. Hattori Y, Akimoto K, Gross SS, Hattori S, Kasai K 2005 Angiotensin-IIinduced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 48:1066-1074
22. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P 2004 Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89:1391-1396
23. Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thone-Reineke C, Unger T, Kintscher U 2005 PPARγ-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 46:137-143
24. Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T, Ohashi K, Hibuse T, Fujita K, Yasui A, Hiuge A, Kumada M, Kuriyama H, Shimomura I, Funahashi T 2006 Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 70:1717-1724
25. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM 1999 Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 17:555-560
26. Hollenberg NK, Chenitz WR, Adams DF, Williams GH 1974 Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54:34-42
27. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Bohm M 1998 Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 31:1272-1277
28. Engeli S, Negrel R, Sharma AM 2000 Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35:1270-1277
29. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G 2002 Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 106:1957-1961
30. Lyons D, Webster J, Benjamin N 1995 1Angiotensin II: adrenergic sympathetic constrictor action in humans. Circulation 91:1457-1460
31. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R 2001 Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507:142-146
32. Nowak L, Adamczak M, Wiecek A 2005 Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 18:1470-1475
33. Ogihara T, Asano T, Ando K, Chiba Y, Sekine N, Sakoda H, Anai M, Onishi Y, Fujishiro M, Ono H, Shojima N, Inukai K, Fukushima Y, Kikuchi M, Fujita T 2001 Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 50:573-583
34. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC 1993 Effect of sodium intake on insulin sensitivity. Am J Physiol 264(5 Pt 1):E730-E734
35. Adamczak M, Kokot F, Chudek J, Wiecek A 2002 Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension. Med Sci Monit 8:CR473-CR477
36. Skurk T, van Harmelen V, Blum WF, Hauner H 2005 Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res 13:969-973
37. Kim S, Whelan J, Claycombe K, Reath DB, Moustaid-Moussa N 2002 Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. J Nutr 132:1135-1140
38. Cassis LA, English VL, Bharadwaj K, Boustany CM 2004 Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 145:169-174
39. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N 2006 Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91:3873-3877
40. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y 2006 Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55:1954-1960